title: Treatment of visceral leishmaniasis with injectable paromomycin (aminosidine). An open-label randomized phase-II clinical study.
authors: Kala-azar Research Centre, Patna, Bihar, India.
authors: C P
authors: CP
authors: Thakur
authors: T P
authors: TP
authors: Kanyok
authors: A K
authors: AK
authors: Pandey
authors: G P
authors: GP
authors: Sinha
authors: C
authors: C
authors: Messick
authors: P
authors: P
authors: Olliaro
mesh_terms: D000328:Adult; D000563:Amebicides / Q000008:administration & dosage* / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007267:Injections; D007898:Leishmaniasis, Visceral / Q000188:drug therapy*; D008297:Male; D010303:Paromomycin / Q000008:administration & dosage* / Q000009:adverse effects; D016896:Treatment Outcome
chemical_list: D000563:Amebicides; D010303:Paromomycin